OpenURL Connection Search

Select item for more details and to access through your institution.

Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma.
Published in:
British Journal of Haematology, 2020, v. 189, n. 6, p. 1074, doi. 10.1111/bjh.16488
By:
- Chakraborty, Rajshekhar;
- Rybicki, Lisa;
- Nakashima, Megan O.;
- Dean, Robert M.;
- Faiman, Beth M.;
- Samaras, Christy J.;
- Rosko, Nathaniel;
- Dysert, Hayley;
- Valent, Jason;
- Anwer, Faiz
Publication type:
Article
Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma.
Published in:
British Journal of Haematology, 2020, v. 189, n. 6, p. 1136, doi. 10.1111/bjh.16454
By:
- Basali, Diana;
- Chakraborty, Rajshekhar;
- Rybicki, Lisa;
- Rosko, Nathaniel;
- Reed, Janice;
- Karam, Maryann;
- Schlueter, Kristen;
- Dysert, Hayley;
- Kalaycio, Matt;
- Valent, Jason
Publication type:
Article
A Phase 1/2 Trial of Low-Dose Continuous Azacitidine in Combination with Lenalidomide and Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e262, doi. 10.1016/j.clml.2019.09.434
By:
- Khouri, Jack;
- Faiman, Beth;
- Wei, Wei;
- Grabowski, Dale;
- Samaras, Christy Joy;
- mahfouz, Reda;
- Lazarus, Hillard;
- Dean, Robert;
- Malek, Eshan;
- Reed, Janice;
- Karam, Mary Ann;
- Hamilton, Kimberly;
- Rosko, Nathaniel;
- Fada, Sherry;
- Kalaycio, Matt;
- Liu, Hien;
- Saunthararajah, Yogen;
- Chew, Yap;
- Valent, Jason;
- Reu, Frederic
Publication type:
Article
Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development.
Published in:
Antibodies (2073-4468), 2019, v. 8, n. 2, p. 34, doi. 10.3390/antib8020034
By:
- Iftikhar, Ahmad;
- Hassan, Hamza;
- Iftikhar, Nimra;
- Mushtaq, Adeela;
- Sohail, Atif;
- Rosko, Nathaniel;
- Chakraborty, Rajshekhar;
- Razzaq, Faryal;
- Sandeep, Sonia;
- Valent, Jason Neil;
- Kanate, Abraham Sebastian;
- Anwer, Faiz
Publication type:
Article

Found: 4

Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma.

Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma.

A Phase 1/2 Trial of Low-Dose Continuous Azacitidine in Combination with Lenalidomide and Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma.

Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development.